Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6094
Rank
NZ$1.16 B
Marketcap
$58.16
Share price
-2.56%
Change (1 day)
-15.16%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement